Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
2 RESEARCH METHODOLOGY 48 5 MARKET OVERVIEW Pharmaceutical giants fuel GLP-1 market expansion, driven by obesity prevalence and innovative oral treatments
Furthermore, managing two weight-loss medications simultaneously increases complexity for both patients and healthcare providers, potentially affecting adherence and monitoring quality
Looking ahead, the Stein Institute for Research on Aging hopes to use these findings to develop personalized "aging dashboards" based on epigenetic clocks
the University of Minnesota
NAION is the second most common optic neuropathy after glaucoma
US$ 21.75
US$ 28.07
US$ 20.79
US$ 25.58
